Diffuse Large B-Cell Lymphoma in Chinese Patients
Authors:
Open Access
- 1 February 2010
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 133 (2) , 305-313
Abstract
In diffuse large B-cell lymphoma (DLBCL), BCL2 expression usually correlates with the t(14;18) (q32;q21) in germinal center B-cell (GCB) subtype and with gain/amplification of chromosome 18q21 in the activated B cell–like subtype. Studies have suggested that the GCB subtype is less common in Chinese than in Western populations. We studied 124 Chinese DLBCL cases using immunohistochemical, conventional cytogenetics, and interphase fluorescence in situ hybridization analyses. A cohort of 114 well-characterized DLBCL cases from Western populations was also analyzed for comparison. Lower incidences of the GCB subtype (P = .0001) and the t(14;18) translocation (P = .0001) were present in Chinese cases. However, BCL2 overexpression was more frequent in Chinese compared with Western cases (P = .0054). BCL2 expression was associated with gain of chromosome 18/18q in the Chinese and Western cohorts. More interestingly, BCL2 expression was associated with gain of chromosome 3/3q in Chinese DLBCL cases, whereas this association was less significant in Western cases.Keywords
This publication has 27 references indexed in Scilit:
- Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphomaHaematologica, 2008
- Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomasBlood, 2008
- High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphomaBlood, 2006
- Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5Blood, 2006
- BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2006
- Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 casesLaboratory Investigation, 2006
- Prognostic Evaluation of Nodal Diffuse Large B Cell Lymphoma by Immunohistochemical Profiles with Emphasis on CD138 Expression as a Poor Prognostic FactorJournal of Korean Medical Science, 2006
- Regulation of NF-κB-Dependent Lymphocyte Activation and Development by ParacaspaseScience, 2003
- Diffuse large cell lymphomaCurrent Opinion in Oncology, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000